- Boise US-ID
Dr. Nancy Kois serves as Attending Pathologist and Chief of Laboratory Medicine at Veteran's Administration Medical Center in Boise, Idaho. Board-certified in anatomic and clinical pathology, and neuropathology, Dr. Nancy Kois is a Fellow of the College of American Pathologists (FCAP), a professional society of board-certified pathologists. Pathology is a branch of medicine that concerns itself with the study of disease, which itself is defined as any disorder or abnormality that alters the function or structure of body parts. Pathology studies four elements of disease: its cause, how it develops, how cells are changed, and the impact of those changes. There are two branches of pathology, clinical and anatomic. Clinical pathology focuses on the diagnosis of disease by examining body fluids in a laboratory setting. Anatomic pathology, on the other hand, represents examination of biopsy tissue samples. Anatomic pathology itself has several subspecialties, among which are forensic, molecular, and surgical pathology, as well as cytopathology, hematopathology, dermatopathology, and neuropathology. Pathologists are trained and licensed physicians who have earned their medical degrees and then completed a significant amount of additional training in residencies and fellowships. Pathologists are certified by the American Board of Pathology in anatomic or clinical pathology, or both, as well as 11 subspecialties, including dermatopathology, neuropathology, and pediatric pathology. Before they can take the certification examination, physicians must have three to four years of specialty training.
An experienced pathologist, Nancy Kois, MD, FCAP, has taken part in a number of diagnostic procedures to help improve preventive procedures for several medical conditions. In the past, Dr. Nancy Kois has teamed up with oncologists and other medical professionals to discuss the latest developments in cancer therapies, one of which is the use of nanotechnology to remove brain tumors. Brain cancer is one of the most difficult diseases to diagnose and treat. Typically it requires surgery followed by chemotherapy and radiation to remove any traces of cancer cells. For children, brain tumors are the number-one cause of cancer-related deaths. Advancements in nanotechnology are helping to treat brain cancer by improving doctors' ability to distinguish good brain cells from cancerous ones, allowing them to remove brain tumors more accurately and thoroughly while preserving normal, healthy brain tissue. For instance, a recently-developed procedure in nanotechnology that turns cancerous cells blue and therefore helps surgeons remove brain tumors more cleanly and leave surrounding healthy cells untouched. This discovery may be most important for hospitals that lack equipment like MRI machines, which are typically used to direct tumor removal, save normal brain tissue, and monitor brain activity during surgery.